close

References

1. Louis ED. Tremor. Continuum (Minneap Minn). 2019;25(4):959-975.
2. Ferreira JJ, Mestre TA, Lyons KE, et al; MDS Task Force on Tremor and the MDS Evidence Based Medicine Committee. MDS evidence-based review of treatments for essential tremor. Mov Disord. 2019;34(7):950-958.
3. Lenze EJ, Mulsant BH, Blumberger DM, et al. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(10011):2404-2412.
4. Wisidagama S, Selladurai A, Wu P, Isetta M, Serra-Mestres J. Recognition and management of antipsychotic-induced parkinsonism in older adults a narrative review. Medicines (Basel). 2021;8(6):24.
5. Pringsheim T, Day GS, Smith DB, et al; Guideline Subcommittee of the AAN. Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee. Neurology. 2021;97(20):942-957.
6. Chou KL, Martello J, Atem J, et al. Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update. Neurology. 2021;97(5):239-245.